)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Hubei Jumpcan Pharmaceutical
Hubei Jumpcan Pharmaceutical (600566) investor relations material
Hubei Jumpcan Pharmaceutical H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 earnings summary24 Apr, 2026
Executive summary
Revenue for 2025 was RMB 6.22 billion, down 22.43% year-over-year; net profit attributable to shareholders was RMB 1.78 billion, down 29.77%.
Decline driven by lower sales of core products and impact of centralized procurement policies.
Company advanced R&D, launched new products, and strengthened digital and quality management.
Maintained strong market positions in pediatric and anti-inflammatory TCM segments.
Financial highlights
Operating income: RMB 6.22 billion, down 22.43% year-over-year.
Net profit attributable to shareholders: RMB 1.78 billion, down 29.77% year-over-year.
Operating cash flow: RMB 1.20 billion, down 44.94% year-over-year.
Basic and diluted EPS: RMB 1.93, down 30.07% year-over-year.
Gross margin remained high at 79.15%.
Outlook and guidance
2026 focus: accelerate innovative drug launches, consolidate core product market share, and deepen retail and hospital channel integration.
Continued investment in R&D and digital transformation to drive long-term growth.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Hubei Jumpcan Pharmaceutical
- Revenue and net profit declined year-over-year, but operating cash flow improved and share buybacks began.600566
Q1 202624 Apr 2026 - Revenue and profit fell, but core market leadership and high dividend payout were maintained.600566H2 202424 Dec 2025
- Revenue and profit dropped over 30% year-over-year amid weak demand and lower product sales.600566Q3 202528 Oct 2025
- Q1 2025 saw steep declines in revenue and profit, with a share repurchase plan underway.600566Q1 202510 Sep 2025
- Revenue and profit dropped over 30% and 45% respectively, with core products under pressure.600566H1 202523 Aug 2025
- Revenue and profit fell year-over-year, with operating cash flow down sharply.600566Q3 202413 Jun 2025
- Revenue declined 12.84% in H1 2024, but net profit and R&D investment remained robust.600566H1 202413 Jun 2025
Next Hubei Jumpcan Pharmaceutical earnings date
Q2 202624 Aug, 2026
Hubei Jumpcan Pharmaceutical
Next Hubei Jumpcan Pharmaceutical earnings date
Q2 202624 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage